UBS Maintains a 'Neutral' on IBM (IBM); New Mainframe Aims for Cloud

August 29, 2012 11:21 AM EDT Send to a Friend
Get Alerts IBM Hot Sheet
Price: $206.99 -0.8%

Rating Summary:
    8 Buy, 15 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 28 | New: 14
Trade IBM Now!
UBS maintains a 'Neutral' on IBM (NYSE: IBM) price target of $203.00.

Analyst, Steven Milunovich, commenting on the company's announcement unveiling zEnterprise EC12, a highly secure system for cloud computing and enterprise data.

Bottom line: New, cutting-edge System z capabilities for security and analytics dramatically boost cloud performance with help from IBM Research innovations.
zEC12 offers 25% more performance per core, over 100 configurable cores and 50% more total capacity than its predecessor. The result of over $1 billion in IBM R&D investment and collaborative client input on today's enterprise system challenges.

Therefore, IBM wants to eventually put WATSON, the famous 'thinking computer' that beat Ken Jennings at Jeopardy...into your phone...but don't expect it to come with the iPhone 5 (Nasdaq: AAPL) 6 or 7. IBM is beginning the process to move data to the cloud for Watson, but there are bigger fish to fry for IBM before the average consumers mobile phone.

Separately, IBM also did make another major announcement, acquiring Kenexa for $46/share.

Kenexa Corporation, is a provider of software-as-a-service, solutions that enable organizations to recruit, retain and develop employees. Its solutions are built around a suite of easily configurable software applications that automate talent acquisition and employee performance management practices.

For an analyst ratings summary and ratings history on IBM click here. For more ratings news on IBM click here.

Shares of IBM closed at $194.87 yesterday, with a 52 week range of $158.76-$210.69.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments

Related Entities

UBS

Add Your Comment